nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—PLA2G4A—Carbachol—glaucoma	0.442	1	CbGbCtD
Fluocinolone Acetonide—NR3C1—glaucoma	0.358	1	CbGaD
Fluocinolone Acetonide—PLA2G4A—Pindolol—Carteolol—glaucoma	0.000758	0.276	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Pindolol—Levobunolol—glaucoma	0.000758	0.276	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Pindolol—Metipranolol—glaucoma	0.000723	0.263	CbGdCrCtD
Fluocinolone Acetonide—Fluocinonide—SMO—glaucoma	0.000675	0.143	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Pindolol—Betaxolol—glaucoma	0.000506	0.184	CbGdCrCtD
Fluocinolone Acetonide—Difluprednate—NR3C1—glaucoma	0.000218	0.046	CrCbGaD
Fluocinolone Acetonide—Clocortolone—NR3C1—glaucoma	0.000211	0.0446	CrCbGaD
Fluocinolone Acetonide—Desonide—NR3C1—glaucoma	0.0002	0.0422	CrCbGaD
Fluocinolone Acetonide—Diflorasone—NR3C1—glaucoma	0.0002	0.0422	CrCbGaD
Fluocinolone Acetonide—Desoximetasone—NR3C1—glaucoma	0.000195	0.0412	CrCbGaD
Fluocinolone Acetonide—Flurandrenolide—NR3C1—glaucoma	0.00017	0.0361	CrCbGaD
Fluocinolone Acetonide—Flumethasone Pivalate—NR3C1—glaucoma	0.000168	0.0354	CrCbGaD
Fluocinolone Acetonide—Halobetasol Propionate—NR3C1—glaucoma	0.000165	0.0349	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.000158	0.144	CbGpPWpGaD
Fluocinolone Acetonide—Budesonide—NR3C1—glaucoma	0.000153	0.0324	CrCbGaD
Fluocinolone Acetonide—Amcinonide—NR3C1—glaucoma	0.000153	0.0324	CrCbGaD
Fluocinolone Acetonide—Fluticasone furoate—NR3C1—glaucoma	0.00015	0.0318	CrCbGaD
Fluocinolone Acetonide—Mometasone—NR3C1—glaucoma	0.000146	0.0308	CrCbGaD
Fluocinolone Acetonide—Rimexolone—NR3C1—glaucoma	0.000144	0.0305	CrCbGaD
Fluocinolone Acetonide—Fluocinonide—NR3C1—glaucoma	0.000136	0.0288	CrCbGaD
Fluocinolone Acetonide—Beclomethasone—NR3C1—glaucoma	0.000136	0.0288	CrCbGaD
Fluocinolone Acetonide—Alclometasone—NR3C1—glaucoma	0.000132	0.0279	CrCbGaD
Fluocinolone Acetonide—Clobetasol propionate—NR3C1—glaucoma	0.000129	0.0272	CrCbGaD
Fluocinolone Acetonide—Flunisolide—NR3C1—glaucoma	0.000129	0.0272	CrCbGaD
Fluocinolone Acetonide—Fludrocortisone—NR3C1—glaucoma	0.000129	0.0272	CrCbGaD
Fluocinolone Acetonide—Paramethasone—NR3C1—glaucoma	0.000127	0.0269	CrCbGaD
Fluocinolone Acetonide—Fluorometholone—NR3C1—glaucoma	0.000124	0.0262	CrCbGaD
Fluocinolone Acetonide—Methylprednisolone—NR3C1—glaucoma	0.00012	0.0253	CrCbGaD
Fluocinolone Acetonide—Dermatitis—Metipranolol—glaucoma	0.000119	0.000622	CcSEcCtD
Fluocinolone Acetonide—Back pain—Travoprost—glaucoma	0.000119	0.00062	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Brinzolamide—glaucoma	0.000119	0.000619	CcSEcCtD
Fluocinolone Acetonide—Headache—Metipranolol—glaucoma	0.000119	0.000618	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Pilocarpine—glaucoma	0.000119	0.000617	CcSEcCtD
Fluocinolone Acetonide—Infection—Bimatoprost—glaucoma	0.000119	0.000617	CcSEcCtD
Fluocinolone Acetonide—Back pain—Brinzolamide—glaucoma	0.000118	0.000612	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Levobunolol—glaucoma	0.000117	0.000611	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Bimatoprost—glaucoma	0.000117	0.000609	CcSEcCtD
Fluocinolone Acetonide—Influenza—Betaxolol—glaucoma	0.000117	0.000607	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Dorzolamide—glaucoma	0.000117	0.000606	CcSEcCtD
Fluocinolone Acetonide—Visual disturbance—Timolol—glaucoma	0.000116	0.000605	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Carteolol—glaucoma	0.000116	0.000605	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Travoprost—glaucoma	0.000116	0.000604	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Carbachol—glaucoma	0.000115	0.0006	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Brinzolamide—glaucoma	0.000115	0.000596	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Pilocarpine—glaucoma	0.000114	0.000595	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Diclofenamide—glaucoma	0.000114	0.000594	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Levobunolol—glaucoma	0.000114	0.000591	CcSEcCtD
Fluocinolone Acetonide—Back pain—Pilocarpine—glaucoma	0.000113	0.000588	CcSEcCtD
Fluocinolone Acetonide—Cough—Brimonidine—glaucoma	0.000113	0.000588	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Timolol—glaucoma	0.000113	0.000588	CcSEcCtD
Fluocinolone Acetonide—Nausea—Metipranolol—glaucoma	0.000113	0.000586	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.000112	0.000584	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Carbachol—glaucoma	0.000112	0.00058	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Dorzolamide—glaucoma	0.000111	0.000578	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Travoprost—glaucoma	0.000111	0.000576	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Brimonidine—glaucoma	0.00011	0.000574	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Timolol—glaucoma	0.00011	0.000573	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Timolol—glaucoma	0.00011	0.000573	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Pilocarpine—glaucoma	0.00011	0.000573	CcSEcCtD
Fluocinolone Acetonide—Headache—Carteolol—glaucoma	0.00011	0.000573	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Diclofenamide—glaucoma	0.00011	0.000572	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Levobunolol—glaucoma	0.00011	0.000571	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Brinzolamide—glaucoma	0.000109	0.000568	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Latanoprost—glaucoma	0.000109	0.000567	CcSEcCtD
Fluocinolone Acetonide—Rash—Diclofenamide—glaucoma	0.000109	0.000567	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Methazolamide—glaucoma	0.000109	0.000566	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Betaxolol—glaucoma	0.000108	0.000564	CcSEcCtD
Fluocinolone Acetonide—Headache—Diclofenamide—glaucoma	0.000108	0.000563	CcSEcCtD
Fluocinolone Acetonide—Cough—Dorzolamide—glaucoma	0.000108	0.000561	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.000108	0.0981	CbGpPWpGaD
Fluocinolone Acetonide—Rhinitis—Clonidine—glaucoma	0.000107	0.000559	CcSEcCtD
Fluocinolone Acetonide—Cough—Travoprost—glaucoma	0.000107	0.000559	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Carbachol—glaucoma	0.000107	0.000558	CcSEcCtD
Fluocinolone Acetonide—Rash—Carbachol—glaucoma	0.000106	0.000553	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000106	0.000553	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Carbachol—glaucoma	0.000106	0.000553	CcSEcCtD
Fluocinolone Acetonide—Cough—Brinzolamide—glaucoma	0.000106	0.000552	CcSEcCtD
Fluocinolone Acetonide—Oedema—Brimonidine—glaucoma	0.000106	0.00055	CcSEcCtD
Fluocinolone Acetonide—Headache—Carbachol—glaucoma	0.000106	0.00055	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Dorzolamide—glaucoma	0.000105	0.000548	CcSEcCtD
Fluocinolone Acetonide—Pain—Apraclonidine—glaucoma	0.000105	0.000548	CcSEcCtD
Fluocinolone Acetonide—Infection—Brimonidine—glaucoma	0.000105	0.000546	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Travoprost—glaucoma	0.000105	0.000545	CcSEcCtD
Fluocinolone Acetonide—Nausea—Carteolol—glaucoma	0.000104	0.000543	CcSEcCtD
Fluocinolone Acetonide—Headache—Levobunolol—glaucoma	0.000104	0.000541	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Betaxolol—glaucoma	0.000104	0.000541	CcSEcCtD
Fluocinolone Acetonide—Infestation—Betaxolol—glaucoma	0.000104	0.000541	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Brimonidine—glaucoma	0.000104	0.000539	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Brinzolamide—glaucoma	0.000104	0.000539	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000103	0.000536	CcSEcCtD
Fluocinolone Acetonide—Nausea—Diclofenamide—glaucoma	0.000103	0.000534	CcSEcCtD
Fluocinolone Acetonide—Pain—Bimatoprost—glaucoma	0.000102	0.000531	CcSEcCtD
Fluocinolone Acetonide—Cough—Pilocarpine—glaucoma	0.000102	0.000531	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Latanoprost—glaucoma	0.000102	0.00053	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Methazolamide—glaucoma	0.000101	0.000526	CcSEcCtD
Fluocinolone Acetonide—Triamcinolone—NR3C1—glaucoma	0.000101	0.0214	CrCbGaD
Fluocinolone Acetonide—Oedema—Dorzolamide—glaucoma	0.000101	0.000525	CcSEcCtD
Fluocinolone Acetonide—Oedema—Travoprost—glaucoma	0.0001	0.000523	CcSEcCtD
Fluocinolone Acetonide—Rash—Methazolamide—glaucoma	0.0001	0.000522	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Methazolamide—glaucoma	0.0001	0.000521	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Clonidine—glaucoma	0.0001	0.000521	CcSEcCtD
Fluocinolone Acetonide—Nausea—Carbachol—glaucoma	0.0001	0.000521	CcSEcCtD
Fluocinolone Acetonide—Infection—Travoprost—glaucoma	9.98e-05	0.000519	CcSEcCtD
Fluocinolone Acetonide—Headache—Methazolamide—glaucoma	9.97e-05	0.000519	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Pilocarpine—glaucoma	9.95e-05	0.000518	CcSEcCtD
Fluocinolone Acetonide—Nausea—Levobunolol—glaucoma	9.86e-05	0.000513	CcSEcCtD
Fluocinolone Acetonide—Infection—Brinzolamide—glaucoma	9.86e-05	0.000513	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Travoprost—glaucoma	9.86e-05	0.000513	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Timolol—glaucoma	9.86e-05	0.000513	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Betaxolol—glaucoma	9.75e-05	0.000507	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Brinzolamide—glaucoma	9.73e-05	0.000506	CcSEcCtD
Fluocinolone Acetonide—Rash—Latanoprost—glaucoma	9.71e-05	0.000505	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Latanoprost—glaucoma	9.7e-05	0.000505	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Clonidine—glaucoma	9.66e-05	0.000503	CcSEcCtD
Fluocinolone Acetonide—Headache—Latanoprost—glaucoma	9.65e-05	0.000502	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Brimonidine—glaucoma	9.63e-05	0.000501	CcSEcCtD
Fluocinolone Acetonide—Oedema—Pilocarpine—glaucoma	9.54e-05	0.000496	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Acetazolamide—glaucoma	9.51e-05	0.000495	CcSEcCtD
Fluocinolone Acetonide—Infection—Pilocarpine—glaucoma	9.48e-05	0.000493	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Clonidine—glaucoma	9.47e-05	0.000493	CcSEcCtD
Fluocinolone Acetonide—Nausea—Methazolamide—glaucoma	9.45e-05	0.000492	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Clonidine—glaucoma	9.39e-05	0.000489	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Betaxolol—glaucoma	9.36e-05	0.000487	CcSEcCtD
Fluocinolone Acetonide—Erythema—Clonidine—glaucoma	9.33e-05	0.000486	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Dorzolamide—glaucoma	9.2e-05	0.000478	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Travoprost—glaucoma	9.16e-05	0.000476	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Brimonidine—glaucoma	9.12e-05	0.000475	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Apraclonidine—glaucoma	9.07e-05	0.000472	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Brinzolamide—glaucoma	9.04e-05	0.00047	CcSEcCtD
Fluocinolone Acetonide—Pain—Brimonidine—glaucoma	9.04e-05	0.00047	CcSEcCtD
Fluocinolone Acetonide—Fluticasone Propionate—NR3C1—glaucoma	9.03e-05	0.0191	CrCbGaD
Fluocinolone Acetonide—Visual impairment—Betaxolol—glaucoma	8.99e-05	0.000468	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Timolol—glaucoma	8.85e-05	0.000461	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Clonidine—glaucoma	8.8e-05	0.000458	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Betaxolol—glaucoma	8.72e-05	0.000454	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Apraclonidine—glaucoma	8.71e-05	0.000453	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Acetazolamide—glaucoma	8.71e-05	0.000453	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Pilocarpine—glaucoma	8.69e-05	0.000452	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Travoprost—glaucoma	8.68e-05	0.000451	CcSEcCtD
Fluocinolone Acetonide—Pain—Dorzolamide—glaucoma	8.63e-05	0.000449	CcSEcCtD
Fluocinolone Acetonide—Pain—Travoprost—glaucoma	8.59e-05	0.000447	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Brinzolamide—glaucoma	8.57e-05	0.000446	CcSEcCtD
Fluocinolone Acetonide—Pain—Brinzolamide—glaucoma	8.49e-05	0.000441	CcSEcCtD
Fluocinolone Acetonide—Prednisolone—NR3C1—glaucoma	8.45e-05	0.0179	CrCbGaD
Fluocinolone Acetonide—Pruritus—Bimatoprost—glaucoma	8.44e-05	0.000439	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Apraclonidine—glaucoma	8.42e-05	0.000438	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Betaxolol—glaucoma	8.41e-05	0.000438	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—NR3C1—glaucoma	8.28e-05	0.0175	CrCbGaD
Fluocinolone Acetonide—Alopecia—Betaxolol—glaucoma	8.25e-05	0.000429	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Pilocarpine—glaucoma	8.23e-05	0.000428	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Betaxolol—glaucoma	8.18e-05	0.000425	CcSEcCtD
Fluocinolone Acetonide—Pain—Pilocarpine—glaucoma	8.16e-05	0.000424	CcSEcCtD
Fluocinolone Acetonide—Cough—Clonidine—glaucoma	8.14e-05	0.000424	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Apraclonidine—glaucoma	8.14e-05	0.000424	CcSEcCtD
Fluocinolone Acetonide—Erythema—Betaxolol—glaucoma	8.12e-05	0.000423	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Betaxolol—glaucoma	8.12e-05	0.000423	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP1B1—glaucoma	8.09e-05	0.0171	CrCbGaD
Fluocinolone Acetonide—Body temperature increased—Dorzolamide—glaucoma	7.98e-05	0.000415	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Timolol—glaucoma	7.97e-05	0.000415	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Betaxolol—glaucoma	7.96e-05	0.000414	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Clonidine—glaucoma	7.95e-05	0.000413	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Bimatoprost—glaucoma	7.89e-05	0.000411	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Apraclonidine—glaucoma	7.83e-05	0.000407	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Brimonidine—glaucoma	7.79e-05	0.000405	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Apraclonidine—glaucoma	7.75e-05	0.000403	CcSEcCtD
Fluocinolone Acetonide—Headache—Apraclonidine—glaucoma	7.71e-05	0.000401	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Betaxolol—glaucoma	7.66e-05	0.000398	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Timolol—glaucoma	7.64e-05	0.000398	CcSEcCtD
Fluocinolone Acetonide—Oedema—Clonidine—glaucoma	7.62e-05	0.000396	CcSEcCtD
Fluocinolone Acetonide—Infection—Clonidine—glaucoma	7.57e-05	0.000394	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Pilocarpine—glaucoma	7.54e-05	0.000392	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Acetazolamide—glaucoma	7.53e-05	0.000392	CcSEcCtD
Fluocinolone Acetonide—Rash—Bimatoprost—glaucoma	7.53e-05	0.000392	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Bimatoprost—glaucoma	7.52e-05	0.000391	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Timolol—glaucoma	7.49e-05	0.00039	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Brimonidine—glaucoma	7.48e-05	0.000389	CcSEcCtD
Fluocinolone Acetonide—Headache—Bimatoprost—glaucoma	7.48e-05	0.000389	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Clonidine—glaucoma	7.47e-05	0.000389	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Dorzolamide—glaucoma	7.44e-05	0.000387	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Travoprost—glaucoma	7.4e-05	0.000385	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Timolol—glaucoma	7.35e-05	0.000382	CcSEcCtD
Fluocinolone Acetonide—Nausea—Apraclonidine—glaucoma	7.31e-05	0.00038	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Brinzolamide—glaucoma	7.31e-05	0.00038	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Betaxolol—glaucoma	7.3e-05	0.00038	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Acetazolamide—glaucoma	7.28e-05	0.000379	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Dorzolamide—glaucoma	7.14e-05	0.000372	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Timolol—glaucoma	7.13e-05	0.000371	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Travoprost—glaucoma	7.11e-05	0.00037	CcSEcCtD
Fluocinolone Acetonide—Cough—Betaxolol—glaucoma	7.09e-05	0.000369	CcSEcCtD
Fluocinolone Acetonide—Nausea—Bimatoprost—glaucoma	7.09e-05	0.000369	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Pilocarpine—glaucoma	7.03e-05	0.000366	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Brinzolamide—glaucoma	7.02e-05	0.000365	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Acetazolamide—glaucoma	7e-05	0.000364	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Brimonidine—glaucoma	6.99e-05	0.000364	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Clonidine—glaucoma	6.94e-05	0.000361	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Betaxolol—glaucoma	6.92e-05	0.00036	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Dorzolamide—glaucoma	6.91e-05	0.000359	CcSEcCtD
Fluocinolone Acetonide—Headache—Acetazolamide—glaucoma	6.9e-05	0.000359	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Travoprost—glaucoma	6.88e-05	0.000358	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Timolol—glaucoma	6.87e-05	0.000358	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Brinzolamide—glaucoma	6.79e-05	0.000353	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Pilocarpine—glaucoma	6.75e-05	0.000351	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Timolol—glaucoma	6.74e-05	0.000351	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Timolol—glaucoma	6.68e-05	0.000348	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Dorzolamide—glaucoma	6.67e-05	0.000347	CcSEcCtD
Fluocinolone Acetonide—Rash—Brimonidine—glaucoma	6.66e-05	0.000347	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Brimonidine—glaucoma	6.66e-05	0.000346	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Travoprost—glaucoma	6.65e-05	0.000346	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Timolol—glaucoma	6.64e-05	0.000345	CcSEcCtD
Fluocinolone Acetonide—Erythema—Timolol—glaucoma	6.64e-05	0.000345	CcSEcCtD
Fluocinolone Acetonide—Oedema—Betaxolol—glaucoma	6.63e-05	0.000345	CcSEcCtD
Fluocinolone Acetonide—Headache—Brimonidine—glaucoma	6.62e-05	0.000344	CcSEcCtD
Fluocinolone Acetonide—Infection—Betaxolol—glaucoma	6.59e-05	0.000343	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Clonidine—glaucoma	6.58e-05	0.000342	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Brinzolamide—glaucoma	6.56e-05	0.000341	CcSEcCtD
Fluocinolone Acetonide—Nausea—Acetazolamide—glaucoma	6.54e-05	0.00034	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Pilocarpine—glaucoma	6.53e-05	0.00034	CcSEcCtD
Fluocinolone Acetonide—Pain—Clonidine—glaucoma	6.51e-05	0.000339	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Betaxolol—glaucoma	6.5e-05	0.000338	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Timolol—glaucoma	6.5e-05	0.000338	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Dorzolamide—glaucoma	6.42e-05	0.000334	CcSEcCtD
Fluocinolone Acetonide—Rash—Dorzolamide—glaucoma	6.36e-05	0.000331	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Dorzolamide—glaucoma	6.36e-05	0.000331	CcSEcCtD
Fluocinolone Acetonide—Rash—Travoprost—glaucoma	6.34e-05	0.00033	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Travoprost—glaucoma	6.33e-05	0.000329	CcSEcCtD
Fluocinolone Acetonide—Headache—Dorzolamide—glaucoma	6.32e-05	0.000329	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Brinzolamide—glaucoma	6.31e-05	0.000328	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Pilocarpine—glaucoma	6.31e-05	0.000328	CcSEcCtD
Fluocinolone Acetonide—Headache—Travoprost—glaucoma	6.3e-05	0.000328	CcSEcCtD
Fluocinolone Acetonide—Nausea—Brimonidine—glaucoma	6.28e-05	0.000327	CcSEcCtD
Fluocinolone Acetonide—Rash—Brinzolamide—glaucoma	6.26e-05	0.000326	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Timolol—glaucoma	6.26e-05	0.000325	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Brinzolamide—glaucoma	6.25e-05	0.000325	CcSEcCtD
Fluocinolone Acetonide—Headache—Brinzolamide—glaucoma	6.22e-05	0.000323	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Pilocarpine—glaucoma	6.06e-05	0.000315	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Betaxolol—glaucoma	6.04e-05	0.000314	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Clonidine—glaucoma	6.02e-05	0.000313	CcSEcCtD
Fluocinolone Acetonide—Rash—Pilocarpine—glaucoma	6.01e-05	0.000313	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Pilocarpine—glaucoma	6.01e-05	0.000313	CcSEcCtD
Fluocinolone Acetonide—Nausea—Dorzolamide—glaucoma	6e-05	0.000312	CcSEcCtD
Fluocinolone Acetonide—Headache—Pilocarpine—glaucoma	5.97e-05	0.000311	CcSEcCtD
Fluocinolone Acetonide—Nausea—Travoprost—glaucoma	5.97e-05	0.000311	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Timolol—glaucoma	5.96e-05	0.00031	CcSEcCtD
Fluocinolone Acetonide—Nausea—Brinzolamide—glaucoma	5.89e-05	0.000307	CcSEcCtD
Fluocinolone Acetonide—Cough—Timolol—glaucoma	5.79e-05	0.000301	CcSEcCtD
Fluocinolone Acetonide—Triamcinolone—PTGS2—glaucoma	5.73e-05	0.0121	CrCbGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Betaxolol—glaucoma	5.72e-05	0.000298	CcSEcCtD
Fluocinolone Acetonide—Pain—Betaxolol—glaucoma	5.67e-05	0.000295	CcSEcCtD
Fluocinolone Acetonide—Nausea—Pilocarpine—glaucoma	5.67e-05	0.000295	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Timolol—glaucoma	5.65e-05	0.000294	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Clonidine—glaucoma	5.61e-05	0.000292	CcSEcCtD
Fluocinolone Acetonide—Oedema—Timolol—glaucoma	5.42e-05	0.000282	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Clonidine—glaucoma	5.39e-05	0.00028	CcSEcCtD
Fluocinolone Acetonide—Infection—Timolol—glaucoma	5.38e-05	0.00028	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Timolol—glaucoma	5.31e-05	0.000276	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Betaxolol—glaucoma	5.24e-05	0.000273	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Clonidine—glaucoma	5.21e-05	0.000271	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Clonidine—glaucoma	5.04e-05	0.000262	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Timolol—glaucoma	4.94e-05	0.000257	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Betaxolol—glaucoma	4.89e-05	0.000254	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Clonidine—glaucoma	4.84e-05	0.000252	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—NR3C1—glaucoma	4.81e-05	0.0102	CrCbGaD
Fluocinolone Acetonide—Rash—Clonidine—glaucoma	4.8e-05	0.00025	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Clonidine—glaucoma	4.8e-05	0.00025	CcSEcCtD
Fluocinolone Acetonide—Headache—Clonidine—glaucoma	4.77e-05	0.000248	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—p38 MAPK Signaling Pathway—TGFB2—glaucoma	4.71e-05	0.0429	CbGpPWpGaD
Fluocinolone Acetonide—Betamethasone—PTGS2—glaucoma	4.7e-05	0.00994	CrCbGaD
Fluocinolone Acetonide—Pruritus—Betaxolol—glaucoma	4.69e-05	0.000244	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Timolol—glaucoma	4.68e-05	0.000243	CcSEcCtD
Fluocinolone Acetonide—Pain—Timolol—glaucoma	4.63e-05	0.000241	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Betaxolol—glaucoma	4.54e-05	0.000236	CcSEcCtD
Fluocinolone Acetonide—Nausea—Clonidine—glaucoma	4.52e-05	0.000235	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	4.4e-05	0.0401	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Betaxolol—glaucoma	4.38e-05	0.000228	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Timolol—glaucoma	4.28e-05	0.000223	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Betaxolol—glaucoma	4.22e-05	0.000219	CcSEcCtD
Fluocinolone Acetonide—Rash—Betaxolol—glaucoma	4.18e-05	0.000218	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Betaxolol—glaucoma	4.18e-05	0.000217	CcSEcCtD
Fluocinolone Acetonide—Headache—Betaxolol—glaucoma	4.15e-05	0.000216	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Signaling events mediated by HDAC Class II—HDAC9—glaucoma	4.07e-05	0.037	CbGpPWpGaD
Fluocinolone Acetonide—Hypersensitivity—Timolol—glaucoma	3.99e-05	0.000208	CcSEcCtD
Fluocinolone Acetonide—Nausea—Betaxolol—glaucoma	3.94e-05	0.000205	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Timolol—glaucoma	3.83e-05	0.000199	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Timolol—glaucoma	3.71e-05	0.000193	CcSEcCtD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—LMX1B—glaucoma	3.66e-05	0.0334	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Timolol—glaucoma	3.58e-05	0.000186	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	3.58e-05	0.0326	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Timolol—glaucoma	3.44e-05	0.000179	CcSEcCtD
Fluocinolone Acetonide—Rash—Timolol—glaucoma	3.42e-05	0.000178	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Timolol—glaucoma	3.41e-05	0.000178	CcSEcCtD
Fluocinolone Acetonide—Headache—Timolol—glaucoma	3.39e-05	0.000177	CcSEcCtD
Fluocinolone Acetonide—Nausea—Timolol—glaucoma	3.22e-05	0.000167	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Arachidonic acid metabolism—CYP1B1—glaucoma	2.94e-05	0.0268	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—glaucoma	2.73e-05	0.00578	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—NCK2—glaucoma	2.61e-05	0.0237	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—SOD1—glaucoma	2.1e-05	0.0191	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	2e-05	0.0182	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—EDN1—glaucoma	1.98e-05	0.018	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—glaucoma	1.76e-05	0.0161	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—MMP1—glaucoma	1.66e-05	0.0151	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Arachidonic acid metabolism—PTGS2—glaucoma	1.33e-05	0.0121	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—HDAC9—glaucoma	1.31e-05	0.012	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—EDN1—glaucoma	1.29e-05	0.0117	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—MMP2—glaucoma	1.24e-05	0.0113	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	1.24e-05	0.0113	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—glaucoma	1.22e-05	0.0111	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	1.19e-05	0.0109	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—NOS3—glaucoma	1.16e-05	0.0106	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—MMP1—glaucoma	1.08e-05	0.00985	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—TGFB2—glaucoma	1.05e-05	0.0096	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	1.05e-05	0.00956	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.02e-05	0.00932	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet homeostasis—NOS3—glaucoma	1.02e-05	0.00925	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CA5A—glaucoma	9.63e-06	0.00877	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NARFL—glaucoma	9.63e-06	0.00877	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—glaucoma	9.53e-06	0.00868	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—glaucoma	9.4e-06	0.00856	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—MMP9—glaucoma	9.32e-06	0.00849	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	9.21e-06	0.00839	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	8.49e-06	0.00773	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	8.43e-06	0.00768	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—SOD1—glaucoma	7.99e-06	0.00728	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CDKN2A—glaucoma	7.67e-06	0.00698	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	7.22e-06	0.00657	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—OPN4—glaucoma	7.16e-06	0.00652	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—BDNF—glaucoma	7.02e-06	0.00639	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—FAS—glaucoma	6.95e-06	0.00633	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CDKN1B—glaucoma	6.79e-06	0.00618	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL1A—glaucoma	6.74e-06	0.00614	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PTGFR—glaucoma	6.45e-06	0.00587	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—MMP9—glaucoma	6.29e-06	0.00573	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—NGF—glaucoma	6.23e-06	0.00567	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	6.17e-06	0.00562	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LRP12—glaucoma	6.1e-06	0.00556	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—FN1—glaucoma	5.56e-06	0.00506	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TGFB2—glaucoma	5.43e-06	0.00495	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CA1—glaucoma	4.7e-06	0.00428	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CTSA—glaucoma	4.56e-06	0.00415	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	4.54e-06	0.00413	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CA2—glaucoma	4.3e-06	0.00392	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	4.3e-06	0.00392	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TP53—glaucoma	4.27e-06	0.00389	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—OPN4—glaucoma	4.23e-06	0.00385	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.21e-06	0.00383	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.21e-06	0.00383	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SOD1—glaucoma	4.12e-06	0.00375	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HEYL—glaucoma	3.93e-06	0.00358	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTGFR—glaucoma	3.81e-06	0.00347	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—glaucoma	3.76e-06	0.00342	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.58e-06	0.00326	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—SMO—glaucoma	3.25e-06	0.00296	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—glaucoma	3.18e-06	0.0029	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MMP1—glaucoma	3.14e-06	0.00286	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.06e-06	0.00279	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TXN—glaucoma	3.03e-06	0.00276	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CAV1—glaucoma	3.01e-06	0.00274	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—CDKN2B—glaucoma	2.98e-06	0.00272	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RPTOR—glaucoma	2.98e-06	0.00272	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—glaucoma	2.97e-06	0.00271	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TNF—glaucoma	2.95e-06	0.00269	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NCK2—glaucoma	2.89e-06	0.00263	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—FN1—glaucoma	2.87e-06	0.00261	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.77e-06	0.00252	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.74e-06	0.0025	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.7e-06	0.00246	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TNF—glaucoma	2.55e-06	0.00232	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HDAC9—glaucoma	2.46e-06	0.00224	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTT1—glaucoma	2.35e-06	0.00214	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS3—glaucoma	2.28e-06	0.00207	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EDN1—glaucoma	2.14e-06	0.00195	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SMO—glaucoma	1.92e-06	0.00175	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.9e-06	0.00173	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—C3—glaucoma	1.87e-06	0.00171	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCA1—glaucoma	1.87e-06	0.00171	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP1B1—glaucoma	1.87e-06	0.00171	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NTRK2—glaucoma	1.76e-06	0.0016	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—glaucoma	1.64e-06	0.00149	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NGFR—glaucoma	1.51e-06	0.00137	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTM1—glaucoma	1.5e-06	0.00136	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—CDKN2B—glaucoma	1.44e-06	0.00131	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NTRK1—glaucoma	1.43e-06	0.0013	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MTHFR—glaucoma	1.32e-06	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN2B—glaucoma	1.32e-06	0.0012	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EDN1—glaucoma	1.27e-06	0.00115	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TP53—glaucoma	1.24e-06	0.00113	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOE—glaucoma	1.23e-06	0.00112	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CAV1—glaucoma	1.22e-06	0.00111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NGF—glaucoma	1.16e-06	0.00106	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—C3—glaucoma	1.11e-06	0.00101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOE—glaucoma	1.03e-06	0.000938	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CAV1—glaucoma	1.02e-06	0.00093	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FN1—glaucoma	9.71e-07	0.000885	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BAD—glaucoma	9.6e-07	0.000874	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NOS3—glaucoma	9.23e-07	0.000841	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—glaucoma	8.44e-07	0.000769	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOS3—glaucoma	7.72e-07	0.000703	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN1B—glaucoma	6.68e-07	0.000609	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP9—glaucoma	6.19e-07	0.000564	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—glaucoma	5.56e-07	0.000506	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TP53—glaucoma	4.2e-07	0.000383	CbGpPWpGaD
